Gong et al. showed that loss of METTL3 promoted cardiomyocytes cell cycle re-entered, infract size decreased and cardiac function improved after myocardial infarction by reducing primary miR-143 m6A modification [28]. This evidence concerns the gene METTL3 and myocardial infarction.